American Para Professional Systems, Clinical Reference Labs, ExamOne, and IMS Paramed have joined forces to create a robust deidentified dataset of life insurance applicants spanning the years 2015-2022. This report finds that there is a concerning industry trend of tobacco misrepresentation in the life insurance industry
Hepatitis Awareness Month in May brings important attention to the gaps in care, helps more people become aware of their risk and screening options, and is an appropriate time for insurers to evaluate their HCV life insurance testing requirements.
ExamOne's cotinine testing data shows that smoking non-disclosure rates for life insurance applicants are up from 27% in 2010 to 43% in 2021. Laboratory testing is the only way to discover who has “smoker’s amnesia.”